Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies

Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies

Field cancerization denotes the occurrence of genetic, epigenetic, and biochemical aberrations in structurally intact cells in histologically normal tissues adjacent to cancerous lesions. This paper tabulates markers of prostate field cancerization known to date and discusses their potential clinica...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kristina A. Trujillo, Anna C. Jones, Jeffrey K. Griffith, Marco Bisoffi
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Prostate Cancer
Online Access:	http://dx.doi.org/10.1155/2012/302894
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
by: Agnieszka Krzyzanowska, et al.
Published: (2025-01-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
by: Pim J. van Leeuwen, et al.
Published: (2016-01-01)

Specimen Orientation by Marking the Peripheral End: (Potential) Clinical Advantages in Prostate Biopsy
by: Andrea Benedetto Galosi, et al.
Published: (2011-01-01)

Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI
by: Maudy C. W. Gayet, et al.
Published: (2020-01-01)

Hepatitis C Transmission after Prostate Biopsy
by: Karim Ferhi, et al.
Published: (2013-01-01)

Magnetic Resonance Image-Guided Biopsies with a High Detection Rate of Prostate Cancer
by: Dirk G. Engehausen, et al.
Published: (2012-01-01)

Impact of Benign Prostatic Hyperplasia Pharmacological Treatment on Transrectal Prostate Biopsy Adverse Effects
by: Marina Zamuner, et al.
Published: (2014-01-01)

3D versus 2D Systematic Transrectal Ultrasound-Guided Prostate Biopsy: Higher Cancer Detection Rate in Clinical Practice
by: Alexandre Peltier, et al.
Published: (2013-01-01)

Evaluation of microRNAs as liquid biopsy markers in adrenocortical tumors
by: Chrysoula Mytareli, et al.
Published: (2025-01-01)

Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy
by: Francis Ting, et al.
Published: (2016-01-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
by: Rustom P. Manecksha, et al.
Published: (2012-01-01)

Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy
by: Alfred Honoré, et al.
Published: (2025-01-01)

The diagnostic performance of indocyanine green for the sentinel node biopsy in prostate cancer: A systematic review and meta-analysis
by: Siyang Ma, et al.
Published: (2025-01-01)

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
by: Diego J. Laderach, et al.
Published: (2013-01-01)

Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
by: Maria E. Pretorius, et al.
Published: (2009-01-01)

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer
by: Carolin Siech, et al.
Published: (2025-02-01)

The Biopsychosocial Burden of Prostate Biopsy at the Time of Its Indication, Procedure, and Pathological Report
by: Walker W. Laranja, et al.
Published: (2019-01-01)

Association between HIV status and Positive Prostate Biopsy in a Study of U.S. Veterans
by: Wayland Hsiao, et al.
Published: (2009-01-01)

Same Day Biopsy and Treatment of Non-Melanoma Skin Cancer in Patients with Field Cancerization: A Retrospective Chart Study
by: Jonathan Miles, et al.
Published: (2023-01-01)

Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
by: Warmusz Oliwia, et al.
Published: (2025-02-01)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
by: Rosaria Alba Merendino, et al.
Published: (2003-01-01)

Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy
by: Susan Scott, et al.
Published: (2023-01-01)

A Pitfall in Transrectal Prostate Biopsy: Malakoplakia Evaluation of Two Cases Based on the Literature Review
by: Dudu Solakoglu Kahraman, et al.
Published: (2014-01-01)

Vulnerabilities of Prostate Glandular Concretions Considered as Artefacts: A Cross-sectional Biopsy Slide Study
by: Surraj SUSAI, et al.
Published: (2023-12-01)

Meta Analysis of Efficacy and Safety of Prostate Biopsy: A Comparison Between Transperineal and Transrectal Approach
by: Syah Mirsya Warli, et al.
Published: (2024-07-01)

A new ASAP Scoring System and Risk Table to predict second prostate biopsy outcomes
by: Ediz Caner, et al.
Published: (2021-10-01)

Prostate Cancer
by: Scott Eggener
Published: (2011-01-01)

THE ORGANIZATION WORKS TO IMPROVE THE CLINICAL AND ECONOMIC OUTCOMES OF CARE FOR PROSTATE CANCER
by: O. I. Apolikhin, et al.
Published: (2015-04-01)

Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
by: Alberto Sánchez Garrido, et al.
Published: (2024-01-01)

Biopsy with the New Essen Biopsy Forceps
by: Peter G. Traine, et al.
Published: (2013-01-01)

Near Fatal Asthma: Clinical and Airway Biopsy Characteristics
by: Richard G. Barbers, et al.
Published: (2012-01-01)

A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis
by: Michael Kongnyuy, et al.
Published: (2015-01-01)

Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning techniques
by: Luis Mariano Esteban, et al.
Published: (2025-02-01)

The Chances of Subsequent Cancer Detection in Patients with a PSA > 20 ng/ml and an Initial Negative Biopsy
by: Nadeem Shaida, et al.
Published: (2009-01-01)

Squared diffusion-weighted imaging for improving the detection of clinically significant prostate cancer
by: Birte Valentin, et al.
Published: (2025-01-01)

Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion
by: Nainesh Parikh MD, MBA, et al.
Published: (2025-01-01)

Corrigendum to “A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis”
by: Michael Kongnyuy, et al.
Published: (2016-01-01)